Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1970 1
1971 2
1972 1
1973 1
1976 1
1980 1
1981 1
1983 1
1984 2
1985 1
1987 2
1988 2
1989 3
1990 8
1991 1
1992 7
1993 2
1994 5
1995 4
1996 11
1997 9
1998 9
1999 13
2000 21
2001 20
2002 43
2003 53
2004 46
2005 51
2006 70
2007 79
2008 103
2009 133
2010 141
2011 116
2012 138
2013 153
2014 190
2015 185
2016 186
2017 233
2018 200
2019 229
2020 248
2021 268
2022 215
2023 51
Text availability
Article attribute
Article type
Publication date

Search Results

2,915 results
Results by year
Filters applied: . Clear all
Page 1
Tumor immune microenvironment lncRNAs.
Park EG, Pyo SJ, Cui Y, Yoon SH, Nam JW. Park EG, et al. Among authors: nam jw. Brief Bioinform. 2022 Jan 17;23(1):bbab504. doi: 10.1093/bib/bbab504. Brief Bioinform. 2022. PMID: 34891154 Free PMC article. Review.
Influenza vaccines: Past, present, and future.
Kim YH, Hong KJ, Kim H, Nam JH. Kim YH, et al. Among authors: nam jh. Rev Med Virol. 2022 Jan;32(1):e2243. doi: 10.1002/rmv.2243. Epub 2021 May 4. Rev Med Virol. 2022. PMID: 33949021 Free PMC article. Review.
Tumor microenvironment and radioresistance.
Suwa T, Kobayashi M, Nam JM, Harada H. Suwa T, et al. Among authors: nam jm. Exp Mol Med. 2021 Jun;53(6):1029-1035. doi: 10.1038/s12276-021-00640-9. Epub 2021 Jun 16. Exp Mol Med. 2021. PMID: 34135469 Free PMC article. Review.
LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy.
Li G, Kryczek I, Nam J, Li X, Li S, Li J, Wei S, Grove S, Vatan L, Zhou J, Du W, Lin H, Wang T, Subramanian C, Moon JJ, Cieslik M, Cohen M, Zou W. Li G, et al. Among authors: nam j. Nat Cell Biol. 2021 May;23(5):526-537. doi: 10.1038/s41556-021-00672-3. Epub 2021 May 6. Nat Cell Biol. 2021. PMID: 33958760 Free PMC article.
Fasting blood glucose as a predictor of mortality: Lost in translation.
Palliyaguru DL, Shiroma EJ, Nam JK, Duregon E, Vieira Ligo Teixeira C, Price NL, Bernier M, Camandola S, Vaughan KL, Colman RJ, Deighan A, Korstanje R, Peters LL, Dickinson SL, Ejima K, Simonsick EM, Launer LJ, Chia CW, Egan J, Allison DB, Churchill GA, Anderson RM, Ferrucci L, Mattison JA, de Cabo R. Palliyaguru DL, et al. Among authors: nam jk. Cell Metab. 2021 Nov 2;33(11):2189-2200.e3. doi: 10.1016/j.cmet.2021.08.013. Epub 2021 Sep 10. Cell Metab. 2021. PMID: 34508697 Free PMC article.
An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B.
Kim HY, Lampertico P, Nam JY, Lee HC, Kim SU, Sinn DH, Seo YS, Lee HA, Park SY, Lim YS, Jang ES, Yoon EL, Kim HS, Kim SE, Ahn SB, Shim JJ, Jeong SW, Jung YJ, Sohn JH, Cho YK, Jun DW, Dalekos GN, Idilman R, Sypsa V, Berg T, Buti M, Calleja JL, Goulis J, Manolakopoulos S, Janssen HLA, Jang MJ, Lee YB, Kim YJ, Yoon JH, Papatheodoridis GV, Lee JH. Kim HY, et al. Among authors: nam jy. J Hepatol. 2022 Feb;76(2):311-318. doi: 10.1016/j.jhep.2021.09.025. Epub 2021 Oct 2. J Hepatol. 2022. PMID: 34606915
Programmable Materials.
Chen X, Gianneschi N, Ginger D, Nam JM, Zhang H. Chen X, et al. Among authors: nam jm. Adv Mater. 2021 Nov;33(46):e2107344. doi: 10.1002/adma.202107344. Adv Mater. 2021. PMID: 34780119 No abstract available.
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial.
Liau LM, Ashkan K, Brem S, Campian JL, Trusheim JE, Iwamoto FM, Tran DD, Ansstas G, Cobbs CS, Heth JA, Salacz ME, D'Andre S, Aiken RD, Moshel YA, Nam JY, Pillainayagam CP, Wagner SA, Walter KA, Chaudhary R, Goldlust SA, Lee IY, Bota DA, Elinzano H, Grewal J, Lillehei K, Mikkelsen T, Walbert T, Abram S, Brenner AJ, Ewend MG, Khagi S, Lovick DS, Portnow J, Kim L, Loudon WG, Martinez NL, Thompson RC, Avigan DE, Fink KL, Geoffroy FJ, Giglio P, Gligich O, Krex D, Lindhorst SM, Lutzky J, Meisel HJ, Nadji-Ohl M, Sanchin L, Sloan A, Taylor LP, Wu JK, Dunbar EM, Etame AB, Kesari S, Mathieu D, Piccioni DE, Baskin DS, Lacroix M, May SA, New PZ, Pluard TJ, Toms SA, Tse V, Peak S, Villano JL, Battiste JD, Mulholland PJ, Pearlman ML, Petrecca K, Schulder M, Prins RM, Boynton AL, Bosch ML. Liau LM, et al. Among authors: nam jy. JAMA Oncol. 2023 Jan 1;9(1):112-121. doi: 10.1001/jamaoncol.2022.5370. JAMA Oncol. 2023. PMID: 36394838 Free PMC article. Clinical Trial.
2,915 results